REGISTERED OFFICE
DRAXIS Health Inc.
TD Bank Tower, Suite 4700
Toronto Dominion Centre
Toronto, Ontario
Canada M5K 1E6

PLACE OF BUSINESS
16751 TransCanada Highway
Kirkland, Québec
Canada H9H 4J4

FORM 20-F
For regulatory purposes in the United States, the Company files an Annual Report on Form 20-F with the United States Securities and Exchange Commission. Form 20-F may be obtained by any shareholder upon request to the Company and is also available on EDGAR at www.sec.gov.

INVESTOR INFORMATION
DRAXIS Health Inc.
Investor Relations
16751 TransCanada Highway
Kirkland, Québec
Canada H9H 4J4

Telephone: 1-877-441-1984 (toll free)
Facsimile: 514-630-7159
Website: www.draxis.com

AUDITORS
Deloitte & Touche LLP

ANNUAL MEETING OF SHAREHOLDERS
The date and location of the annual meeting of shareholders will be provided in the Management Proxy Circular and will be posted on the Company website at www.draxis.com. Shareholders may also contact DRAXIS Investor Relations or our Transfer Agent and Registrar (see below).

Common shares of DRAXIS Health Inc. are listed on the Toronto Stock Exchange (“TSX”) and on The Nasdaq Stock Market, Inc. (“NASDAQ”).

In 2007 share trading volume on the TSX was 23,298,114 shares (average of 92,453 per trading day) and on NASDAQ was 27,575,417 shares (average of 109,862 per trading day).

TRANSFER AGENT AND REGISTRAR
Computershare Investor Services
100 University Avenue
9th Floor
Toronto, Ontario
Canada M5J 2Y1

Telephone:
1-800-564-6253 (toll free in Canada and the United States)
514-982-7555 (international direct dial)
Facsimile: 1-888-453-0330